Multinational Ambispective Study of the Clinical Management and Burden of Bipolar Disorder (WAVE bd Study).
Phase of Trial: Phase IV
Latest Information Update: 22 May 2012
At a glance
- Drugs Neuropsychotherapeutics; Quetiapine
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Acronyms WAVE bd
- Sponsors AstraZeneca
- 22 May 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 22 May 2012 Additional trial location (Ukraine) identified as reported by ClinicalTrials.gov.
- 15 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.